Market Gems:Stocks w/Strong Earnings and High Tech. Rank Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Long John who wrote (96819)	5/9/2000 3:16:00 PM
From: Jenna	Read Replies (1) of 120523

PROX +8 1/2.. called timely yikes. John look at SUPX and KNT also nice report and moving up. Waited for that one to report and now its heading swiftly to new high. A biotech as new IPO another potential short there. Credit Suisse First Boston priced a 6 million-share IPO for Orchid Biosciences (ORCH:Nasdaq) at the bottom of its revised price range at $8 a share. Orchid Biosciences climbed 2 15/16, or 36.7%, to 10 15/16 its not climbing now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next